18:0 DAP

• Description :

  18:0 DAP can be used to formulate lipid nanoparticles (LNPs), which mRNA is encapsulated in their core[1].

• UNSPSC :

  12352200

• Hazard Statement :

  H302, H315, H319, H331, H336, H351, H361, H372

• Target :

  Liposome

• Type :

  Biochemical Assay Reagents

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/18-0-dap.html

• Purity :

  99.99

• Solubility :

  10 mM in DMSO

• Smiles :

  CN(CC(OC(CCCCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O)C

• Molecular Formula :

  C41H81NO4

• Molecular Weight :

  652.09

• Precautions :

  H302, H315, H319, H331, H336, H351, H361, H372

• References & Citations :

  [1]Patel S, et al. Lipid nanoparticles for delivery of messenger RNA to the back of the eye. J Control Release. 2019;303:91-100.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C, 3 years (Powder)

• Scientific Category :

  Biochemical Assay Reagents

• Clinical Information :

  No Development Reported

• CAS Number :

  [121315-93-3]